To ask the Secretary of State for Health what assessment the National Institute for Health and Clinical Excellence has made of the potential role of homecare in the approval and introduction of new drugs.
The National Institute for Health and Clinical Excellence (NICE) has made no such assessment and there are no plans to ask NICE to do so.
When appraising a drug NICE takes account of any relevant costs or benefits associated with the delivery of the drug in different health care settings.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.